33
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512550
319423
2
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Get premium
Close
Create a timeline
Public timelines
FAQ
About & Feedback
Terms
Privacy
FAQ
Support 24/7
Cabinet
Get premium
Donate
jan 1, 1997 - Rituximab
Description:
For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.
Added to timeline:
Cancer
By
Trinity Ozias
14 Nov 2019
0
0
299
Date:
jan 1, 1997
Now
~ 28 years ago
About & Feedback
Terms
Privacy
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL